Media stories about LHC Group (NASDAQ:LHCG) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. LHC Group earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave news coverage about the health services provider an impact score of 45.0371488771418 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the news articles that may have effected Accern Sentiment’s analysis:

LHC Group (NASDAQ:LHCG) traded up $1.40 on Friday, hitting $67.93. The stock had a trading volume of 815,800 shares, compared to its average volume of 139,975. LHC Group has a 52 week low of $41.66 and a 52 week high of $76.14. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market cap of $1,216.15, a P/E ratio of 28.55, a PEG ratio of 1.97 and a beta of 0.70.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.04. The company had revenue of $272.90 million during the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business’s quarterly revenue was up 18.2% on a year-over-year basis. During the same period last year, the business earned $0.54 EPS. equities analysts forecast that LHC Group will post 2.4 earnings per share for the current year.

LHCG has been the subject of a number of recent analyst reports. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $75.00 price target on shares of LHC Group in a research report on Friday, November 3rd. Royal Bank Of Canada increased their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 7th. Oppenheimer Holdings, Inc. increased their price objective on LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 7th. Zacks Investment Research downgraded LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Finally, Bank of America Corporation initiated coverage on LHC Group in a research note on Monday, August 21st. They issued a “buy” rating and a $76.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $76.90.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/17/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-lhc-group-lhcg-stock-price.html.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the transaction, the chief operating officer now owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 14.80% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.